The European Society for Hemapheresis - short ESFH - was founded in 1984 with the aim of gathering European physicians, scientists, and allied health personnel working in the field of Hemapheresis with a vision to improve donor and patient care. The mission of ESFH is to advance knowledge in apheresis techniques through education, to consolidate and spread proven methods, and to open new paths in the collection of blood cells and treatment of diseases by apheresis.

Learn More

From the literature:

ESFH 20th Congress  2018
13th/14th June 2018, Hospital La Fe, Valencia, Spain


 General Assembly Thursday, June 14th, 12:00 -13:00

ESFH 2018 Valencia Web

The meeting will cover relevant aspects regarding clinical, technical and quality management, as well as novel research areas in apheresis and transfusion medicine. Topics discussed in this meeting will include extracorporeal photochemotherapy, plasmapheresis and self-sufficiency in Europe, ultrasounds and peripheral venous access, CAR-T cell therapies, poor mobilizers management, pathogen inactivation technologies, immunoadsorption and thrombotic microangiopathies.

Webinars produced  by Terumo BCT with the collaboration of ESFH

Anticoagulation Management in Therapeutic Plasma Exchange 

Plasma Exchange: Multiple Venous Access Versus Peripheral Access?

What Technology Would You Use for Plasma Exchange?

Advancing Apheresis in Neurology: Review of Neurological Disease Indications for Plasma Exchange

Recently an interesting investigation was published in Vox Sanguinis concerning in vitro evaluation of buffy coat derived granulocytes for the...
In this paper, the group from Pamplona shows data of stem cell mobilization with filgrastim (G-CSF) in 36 healthy family donors, of which 18...
In this paper the authors reviewed more than 50.000 extracorporeal procedures in 7.142 patients regarding incidence and severity of apheresis...